Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 463.54 | 461.33 | 357.09 | 193.35 |
Total Revenue | 463.54 | 461.33 | 357.09 | 193.35 |
Costof Revenue Total | 422.48 | 430.95 | 337.90 | 179.30 |
Gross Profit | 41.06 | 30.38 | 19.19 | 14.05 |
Selling/ General/ Admin Expenses Total | 3.64 | 3.89 | 2.43 | 1.62 |
Depreciation/ Amortization | 1.24 | 0.91 | 0.87 | 0.74 |
Other Operating Expenses Total | 12.00 | 10.45 | 5.23 | 4.89 |
Total Operating Expense | 439.37 | 446.20 | 346.43 | 186.55 |
Operating Income | 24.17 | 15.14 | 10.67 | 6.80 |
Interest Inc( Exp) Net- Non- Op Total | -89.45 | -42.40 | -28.71 | -28.56 |
Net Income Before Taxes | 15.23 | 9.50 | 7.19 | 3.57 |
Provisionfor Income Taxes | 3.77 | 2.46 | 1.89 | 0.90 |
Net Income After Taxes | 11.46 | 7.04 | 5.30 | 2.67 |
Net Income Before Extra Items | 11.46 | 7.04 | 5.30 | 2.67 |
Net Income | 11.46 | 7.04 | 5.30 | 2.67 |
Total Adjustmentsto Net Income | 0.00 | - | - | - |
Income Availableto Com Excl Extra Ord | 11.46 | 7.04 | 5.30 | 2.67 |
Income Availableto Com Incl Extra Ord | 11.46 | 7.04 | 5.30 | 2.67 |
Diluted Net Income | 11.46 | 7.04 | 5.30 | 2.67 |
Diluted Weighted Average Shares | 2.41 | 1.29 | 0.97 | 0.97 |
Diluted EPS Excluding Extra Ord Items | 4.76 | 5.48 | 5.44 | 2.74 |
Diluted Normalized EPS | 4.76 | 5.61 | 5.52 | 2.74 |
Gain( Loss)on Saleof Assets | - | -2.37 | -0.99 | - |
Other Net | - | -1.16 | -0.51 | -0.37 |
DPS- Common Stock Primary Issue | - | 0.30 | 0.00 | 0.00 |
Sudarshan Pharma Industries Dividend Sudarshan Pharma Industries Bonus Sudarshan Pharma Industries News Sudarshan Pharma Industries AGM Sudarshan Pharma Industries Rights Sudarshan Pharma Industries Splits Sudarshan Pharma Industries Board Meetings Sudarshan Pharma Industries Key Metrics Sudarshan Pharma Industries Shareholdings Sudarshan Pharma Industries Balance Sheet Sudarshan Pharma Industries Cashflow Sudarshan Pharma Industries Q1 Results Sudarshan Pharma Industries Q2 Results Sudarshan Pharma Industries Q3 Results Sudarshan Pharma Industries Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks